IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MOSCHESE, DAVIDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.031
NA - Nord America 1.386
EU - Europa 1.280
SA - Sud America 199
AF - Africa 70
OC - Oceania 5
Totale 4.971
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.337
CN - Cina 729
SG - Singapore 596
IT - Italia 493
VN - Vietnam 184
DE - Germania 181
HK - Hong Kong 163
RU - Federazione Russa 157
BR - Brasile 155
BD - Bangladesh 87
FR - Francia 86
NL - Olanda 85
IN - India 81
GB - Regno Unito 72
ID - Indonesia 62
ES - Italia 50
CI - Costa d'Avorio 41
SE - Svezia 39
KR - Corea 29
FI - Finlandia 27
CA - Canada 26
JP - Giappone 25
IE - Irlanda 20
TR - Turchia 17
AT - Austria 14
MX - Messico 14
PL - Polonia 14
AR - Argentina 13
ZA - Sudafrica 11
CL - Cile 8
IQ - Iraq 7
MK - Macedonia 7
PE - Perù 7
DK - Danimarca 6
TW - Taiwan 6
AU - Australia 5
CH - Svizzera 5
AZ - Azerbaigian 4
BE - Belgio 4
EC - Ecuador 4
HR - Croazia 4
IR - Iran 4
JO - Giordania 4
KZ - Kazakistan 4
MA - Marocco 4
PY - Paraguay 4
SA - Arabia Saudita 4
IL - Israele 3
LT - Lituania 3
LV - Lettonia 3
MY - Malesia 3
PK - Pakistan 3
SC - Seychelles 3
UA - Ucraina 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
CO - Colombia 2
ET - Etiopia 2
NP - Nepal 2
RO - Romania 2
RW - Ruanda 2
TN - Tunisia 2
UY - Uruguay 2
VE - Venezuela 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
BH - Bahrain 1
CD - Congo 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MZ - Mozambico 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
Totale 4.971
Salva come PNG Salva come JPEG
Città #
Singapore 304
Ashburn 249
Milan 183
San Jose 138
Hefei 133
Hong Kong 131
Dallas 125
Beijing 104
Frankfurt am Main 100
Los Angeles 66
Ho Chi Minh City 60
Council Bluffs 52
Santa Clara 49
Bengaluru 48
New York 45
Hanoi 44
The Dalles 44
Chandler 42
Abidjan 41
Munich 37
Rome 36
Moscow 35
Lauterbourg 32
Valencia 32
Buffalo 28
Boardman 26
Jakarta 26
Southend 23
Guangzhou 22
Seoul 21
Dublin 20
Nuremberg 17
Tokyo 17
Columbus 15
Bologna 14
London 14
São Paulo 14
Wuhan 14
Da Nang 13
Cangzhou 12
Chicago 12
Florence 12
Shanghai 11
Warsaw 11
Naples 10
Turku 10
Brooklyn 9
Elk Grove Village 9
Helsinki 9
Orem 9
Bollate 8
City of London 8
Haiphong 8
Lappeenranta 8
Lucca 8
Madrid 8
Palermo 8
Seattle 8
Atlanta 7
Boston 7
Genoa 7
Istanbul 7
Johannesburg 7
Montreal 7
Phoenix 7
Skopje 7
Austin 6
Denver 6
Des Moines 6
New Delhi 6
Paris 6
Porto Alegre 6
Princeton 6
Roubaix 6
Shenyang 6
Shenzhen 6
St Petersburg 6
Wanghailou 6
Amsterdam 5
Baltimore 5
Chennai 5
Lentate sul Seveso 5
Lima 5
Piscataway 5
San Francisco 5
Stockholm 5
Thái Nguyên 5
Toronto 5
Yongin-si 5
Amman 4
Bandung 4
Barnet 4
Berlin 4
Bodio Lomnago 4
Carlentini 4
Fuzhou 4
Houston 4
Izmir 4
Lakewood 4
Pontianak 4
Totale 2.819
Salva come PNG Salva come JPEG
Nome #
Isolation of viable monkeypox virus from anal and urethral swabs, Italy, May to July 2022 297
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 280
Antigen-agnostic identification of poxvirus broadly neutralizing antibodies targeting OPG153 253
Dynamics of viral DNA shedding and culture viral DNA positivity in different clinical samples collected during the 2022 mpox outbreak in Lombardy, Italy 225
Surge of Mpox cases in Lombardy region, Italy, October 2023 - January 2024 194
Anal HPV prevalence in individuals with and without other concomitant sexually transmitted infections 194
Viral bloodstream detection in mpox patients: An observational multicentric study 175
Hospitalisation for monkeypox in Milan, Italy 169
Evaluation of analytical performance of the STANDARDTM M10 MPX/OPX assay for the simultaneous DNA detection and clade attribution of Monkeypox virus 166
Early results from implementation of HIV pre-exposure prophylaxis (PrEP) with long-acting injectable cabotegravir for people with barriers to oral strategies, Italy, December 2024 to August 2025 150
Breakthrough Acute HIV Infections among Pre-Exposure Prophylaxis Users with High Adherence: A Narrative Review 146
Effectiveness and safety of tenofovir alafenamide/emtricitabine/bictegravir as a first-line regimen in people with HIV: A retrospective observational study 139
High prevalence of high-risk HPV genotypes in individuals attending an infectious diseases clinic from 2018 to 2022 in Milan, Italy 139
Hepatitis C virus-related factors associated WITH cognitive performance in HIV-HCV-coinfected patients 136
Treatment Experienced People Living with HIV switching to DOR/3TC/TDF in Outpatient Setting: Real-World Data on Tolerability and Cost Savings from an Italian Multicenter Cohort 126
Proportion of newly diagnosed persons with HIV with HIV-RNA greater than/equal to 500,000 copies/mL in 2018-2023 in Italy: data from the ICONA Foundation Cohort Study 121
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 120
Route of monkeypox viral inoculum as a determinant of atypical clinical presentation 118
Is smallpox vaccination protective against human monkeypox? 118
Neutralizing antibody titers induced by JYNNEOS vaccine in unrecognized previous mpox virus exposed individuals 115
Natural history of human Monkeypox in individuals attending a sexual health clinic in Milan, Italy 112
Detection and typization of HPV genotypes in subjects with oral and upper respiratory tract lesions, Milan, Italy 107
Comparing the long-term effectiveness and safety of dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide fumarate as first-line regimens: a real life multicentre cohort 103
Role of multi-site sampling in the diagnosis of human Monkeypox 101
New challenges in human monkeypox outside Africa: A review and case report from Italy 100
Long-term durability of dolutegravir plus darunavir/cobicistat dual regimen in highly antiretroviral-experienced people with HIV (DoDaco study) 91
Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona) 88
Drug Shortages Highlight the Need for Expanded Treatment Options for Syphilis 86
Ongoing sporadic monkeypox cases: neutralising antibody detection in asymptomatic individuals 85
Fostemsavir to overcome drug–drug interactions in heavily treatment-experienced people with HIV and cancer 84
Eliminating cervical cancer: Don't forget HPV test and vaccination in men 83
High effectiveness of ceftriaxone monotherapy and limited value of routine test-of-cure for Gonorrhoea in a low-resistance setting 82
Potential Misleading Interpretation of Molecular Methods in Mpox Infection Control 81
Brief Report: Switching to Long-Acting CAB/RPV: Data From an Italian Monocentric Cohort 79
Switching to deltoid intramuscular injections maintains therapeutic trough concentrations of rilpivirine and cabotegravir in people with HIV 78
Rilpivirine and cabotegravir trough concentrations in people with HIV on long-term treatment with long-acting injectable antiretrovirals 77
Re-emergence of Mpox associated with a distinct MPXV clade: implications for public health and stigma mitigation 66
Evolution of causes of death in People with HIV between 2000 and 2023: a single center retrospective Study 59
Comment on: Doravirine plus lamivudine two-drug regimen as maintenance antiretroviral therapy in people living with HIV: a French observational study 47
Management of asymptomatic bacterial STIs and doxycycline postexposure prophylaxis: consensus statement of the Italian Society of Infectious and Tropical Diseases 29
Impact of sex, age and body composition on rilpivirine and cabotegravir trough concentrations in people with HIV receiving long-acting injectable antiretroviral therapy 25
Mental health, stigma and risk perception among early adopters of HIV PrEP with LA Cabotegravir in Italy: a multicenter cross-sectional and implementation study 15
Synchronous primary neoplasms of the bladder, skin and breast in a male patient: A case report 14
HIV-1 non-R5 tropism correlates with a larger size of the cellular viral reservoir and a detectable residual viremia in patients under suppressive ART 14
Authors' response: Addressing the blind spot of self-reported adherence in the era of long-acting PrEP 14
Residual respiratory impairment after COVID-19 pneumonia 13
Inflammation markers in virologically suppressed HIV-Infected patients after switching to dolutegravir plus lamivudine vs continuing triple therapy: 48-week results in real-life setting 11
Evaluation of doravirine-based regimen population target in a large Italian clinical center 10
Deltoid Administration of LAI-ART: Pharmacokinetic Implications When the Gluteal Site Is Not Feasible 10
Seminal plasma concentrations of long-acting cabotegravir in men receiving HIV pre-exposure prophylaxis 10
A multistep approach to manage Fournier's gangrene in a patient with unknown type II diabetes: Surgery, hyperbaric oxygen, and vacuum-assisted closure therapy: A case report 9
High Rates of Drug Use and Chemsex Among PrEP Users and People with HIV in Milan Highlight Need for Targeted Interventions 9
Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: A retrospective study from the clinical practice 9
Predicting In-Hospital Mortality in COVID-19 Older Patients with Specifically Developed Scores 8
Are we ready for long-acting? A feasibility evaluation of long-acting cabotegravir–rilpivirine in clinical practice 8
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in children with household exposure to adults with COVID-19: Preliminary findings 6
null 3
Totale 5.207
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.658
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.658
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 0 1 7
2021/202232 4 3 2 2 1 0 0 1 5 2 1 11
2022/2023179 6 6 3 13 34 32 5 17 28 1 27 7
2023/2024348 20 9 13 17 61 32 16 20 10 31 68 51
2024/20251.255 60 157 25 74 95 30 80 66 81 152 163 272
2025/20263.308 317 333 408 286 193 144 328 165 358 437 339 0
Totale 5.207